Vertigo Clinical Trial
Official title:
Impact of Vertigoheel® on Patients Suffering From Bilateral Vestibulopathy and Functional Dizziness in a Real-world Setting, Using PRO and QoL - a Non-interventional, Prospective, Mono-center, Observational Study
In this study the researcher observe how vertigo symptoms change during two months of treatment with the natural medicinal product Vertigoheel©. Adult patients suffering from vertigo symptoms can participate if they are diagnosed with bilateral vestibulopathy (BVP) or functional dizziness (FD) and assigned to Vertigoheel treatment. Participating patients receive an examination at study start and after 2 months of Vertigoheel treatment. The study focuses on patient reported outcomes assessed by questionnaires. Vertigo symptoms are assessed by the Dizziness Handicap Inventory questionnaire. Patients' quality of life is assessed by a questionnaire. Body sway is assessed by static posturography. FD patients are additionally tested for depressive and anxiety symptoms by questionnaires. BVP patients are additionally tested for vestibular function by video head impulse test and caloric testing. Adverse events and other observations related to safety (physical examination and vital signs) are evaluated. Vertigo is a common symptom with significant adverse effects on patients' quality of life. Regardless of the exact cause of vertigo attacks, it is important to reduce the frequency, intensity, and duration of vertigo attacks with an effective medication that has no or minimal adverse effect. Vertigoheel®, a natural medicinal product consisting of four ponderable active ingredients, is approved in Germany as treatment for vertigo of various origins. However, no systematic data are available for Vertigoheel® regarding patient-reported outcomes in BVP and FD as the most accepted endpoint in vertigo studies.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Recruiting |
NCT05533840 -
Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
|
||
Completed |
NCT02533739 -
Vestibular Disorder and Visuo-spatial Functions
|
N/A | |
Completed |
NCT01153789 -
Study of Oculomotor Dysfunction Leading to Children Vertigo
|
N/A | |
Completed |
NCT00765635 -
Chlorobutanol, Potassium Carbonate, and Irrigation in Cerumen Removal
|
Phase 4 | |
Not yet recruiting |
NCT04929444 -
Training to Improve Vertigo Management in Primary Care
|
N/A | |
Not yet recruiting |
NCT04055766 -
A Diagnostic Test on DeepDoc-an AI-based Decision Support System
|
||
Completed |
NCT04458376 -
Internet-based Self-help Program for Vestibular Rehabilitation in Chronic Dizziness
|
N/A | |
Recruiting |
NCT06332326 -
Investigation of the Efficacy of Non-Invasive Vagus Nerve Stimulation and Physiotherapy in Unilateral Vestibular Hypofunction Patients
|
N/A | |
Completed |
NCT02938221 -
Telemedical Examination of a Three-Component Oculomotor Testing Battery
|
N/A | |
Active, not recruiting |
NCT02655575 -
Assessment and Treatment of Patients With Long-term Dizziness in Primary Care
|
N/A | |
Completed |
NCT02457455 -
Urgent Medical and Surgical Conditions During Flights
|
N/A | |
Enrolling by invitation |
NCT01426932 -
The Head Impulse Test in the Screening of Vestibular Function
|
N/A | |
Completed |
NCT00000359 -
Treatments for Benign Paroxysmal Positional Vertigo (BPPV)
|
Phase 2 | |
Not yet recruiting |
NCT06017466 -
Translation and Implementation of the Dutch VVAS Score in Clinical Practice
|
N/A | |
Not yet recruiting |
NCT06010550 -
Validating a Clinical Decision Support Tool for Stratifying Stroke Risk for Dizziness/Vertigo
|
||
Completed |
NCT04598113 -
Effect of Cervical Traction on Balance in Cervical Radiculopathy Patients
|
N/A | |
Completed |
NCT05157399 -
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
|
N/A | |
Completed |
NCT05221892 -
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
|
Phase 4 | |
Completed |
NCT02253524 -
Comparison of Efficacy Dimenhydrinate and Metoclopramide in the Treatment of Nausea Due to Vertigo
|
Phase 4 |